Imaging spectrum of NUT carcinomas.

[1]  B. Burkey,et al.  Clinical management of emerging sinonasal malignancies , 2020, Head & neck.

[2]  M. Ahn,et al.  Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review , 2020, Head & neck.

[3]  Joe Y. Chang,et al.  NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[4]  G. Shapiro,et al.  Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors , 2019, JNCI cancer spectrum.

[5]  S. Sallan,et al.  An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients , 2019, JNCI cancer spectrum.

[6]  C. Messina,et al.  NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity. , 2019, Critical reviews in oncology/hematology.

[7]  D. Ginat,et al.  Updated WHO nomenclature of head and neck lesions and associated imaging findings , 2019, Insights into Imaging.

[8]  K. Saluja,et al.  Sinonasal undifferentiated carcinoma: clinicopathologic spectrums and diagnosis reappraisal. , 2019, Human pathology.

[9]  J. Ko,et al.  Spectrum of Lung Adenocarcinoma. , 2019, Seminars in ultrasound, CT, and MR.

[10]  F. Abtin,et al.  Midline carcinoma expressing NUT in malignant effusion cytology , 2019, Diagnostic cytopathology.

[11]  B. Goeppert,et al.  NUT carcinoma in a nutshell: A diagnosis to be considered more frequently. , 2019, Pathology, research and practice.

[12]  Jeong Hyun Lee,et al.  A Scoring System for Prediction of Cervical Lymph Node Metastasis in Patients with Head and Neck Squamous Cell Carcinoma , 2019, American Journal of Neuroradiology.

[13]  Dong-Wan Kim,et al.  Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study. , 2019, The oncologist.

[14]  C. French.  NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment , 2018, Pathology international.

[15]  F. Janot,et al.  Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study , 2018, International forum of allergy & rhinology.

[16]  G. Leverger,et al.  NUT carcinoma in children and adults: A multicenter retrospective study , 2017, Pediatric blood & cancer.

[17]  M. Egger,et al.  Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis. , 2017, Oral oncology.

[18]  Roman K. Thomas,et al.  Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma , 2017, Cell reports.

[19]  G. Rath,et al.  Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases , 2017, European Archives of Oto-Rhino-Laryngology.

[20]  P. D. Dal Cin,et al.  Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma , 2017, Proceedings of the National Academy of Sciences.

[21]  S. Peters,et al.  A phase Ib trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors , 2016 .

[22]  J. Bradner,et al.  Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck , 2016, Cancer.

[23]  J. Bishop,et al.  Cytopathologic features of NUT midline carcinoma: A series of 26 specimens from 13 patients , 2016, Cancer cytopathology.

[24]  G. Pelosi,et al.  Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. , 2016, Cancer discovery.

[25]  A. Forastiere,et al.  Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. , 2016, Mayo Clinic proceedings.

[26]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  M. Mino‐Kenudson,et al.  Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[28]  D. Bell,et al.  Histone deacetylase inhibitor for NUT midline carcinoma , 2015, Pediatric blood & cancer.

[29]  R. Bair,et al.  Demystifying NUT midline carcinoma: radiologic and pathologic correlations of an aggressive malignancy. , 2014, AJR. American journal of roentgenology.

[30]  C. Antonescu,et al.  NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. , 2014, Cancer discovery.

[31]  J. Aster,et al.  MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma , 2014, Oncogene.

[32]  B. Costello,et al.  NUT midline carcinoma: an aggressive intrathoracic neoplasm. , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  C. French.  The Importance of Diagnosing NUT Midline Carcinoma , 2013, Head and Neck Pathology.

[34]  J. Bradner,et al.  Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma , 2012, Clinical Cancer Research.

[35]  J. Bishop,et al.  NUT Midline Carcinomas of the Sinonasal Tract , 2012, The American journal of surgical pathology.

[36]  Mio Tanaka,et al.  NUT Midline Carcinoma: Report of 2 Cases Suggestive of Pulmonary Origin , 2012, The American journal of surgical pathology.

[37]  C. French.  Pathogenesis of NUT midline carcinoma. , 2012, Annual review of pathology.

[38]  J. Teruya-Feldstein,et al.  Radiologic features of NUT midline carcinoma in an adolescent , 2012, Pediatric Radiology.

[39]  Kiery A. Braithwaite,et al.  NUT midline carcinoma: an imaging case series and review of literature , 2012, Pediatric Radiology.

[40]  D. Ettinger,et al.  NCCN Clinical Practice Guidelines Occult primary. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

[41]  Charles A Powell,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. , 2011, Proceedings of the American Thoracic Society.

[42]  M. J. Cameron,et al.  FDG PET/CT imaging of NUT midline carcinoma. , 2011, Clinical nuclear medicine.

[43]  M. Teo,et al.  NUT midline carcinoma in a young woman. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  J. Aster,et al.  Differentiation of NUT midline carcinoma by epigenomic reprogramming. , 2011, Cancer research.

[45]  E. Stelow.  A Review of NUT Midline Carcinoma , 2011, Head and neck pathology.

[46]  C. French,et al.  NUT Midline Carcinoma in a Newborn with Multiorgan Disseminated Tumor and a 2-Year-Old with a Pancreatic/Hepatic Primary , 2010, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[47]  C. French.  NUT midline carcinoma. , 2010, Cancer genetics and cytogenetics.

[48]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[49]  Edward Y Lee,et al.  BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings. , 2010, Journal of thoracic imaging.

[50]  James Ziai,et al.  NUT Gene Rearrangement in a Poorly-differentiated Carcinoma of the Submandibular Gland , 2010, Head and neck pathology.

[51]  M. Rubin,et al.  Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody , 2009, The American journal of surgical pathology.

[52]  J. Aster,et al.  BRD–NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells , 2008, Oncogene.

[53]  G. Gladish,et al.  Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.

[54]  F. Mertens,et al.  Successful treatment of a child with t(15;19)‐positive tumor , 2007, Pediatric blood & cancer.

[55]  R. Munden,et al.  PET/CT Imaging of Lung Cancer , 2006, Journal of thoracic imaging.

[56]  M. Dictor,et al.  Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy , 2006, BMC Cancer.

[57]  C. Antonescu,et al.  Midline carcinoma of children and young adults with NUT rearrangement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[58]  K. Kostikas,et al.  Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. , 2004, Lung cancer.

[59]  J. Fletcher,et al.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. , 2003, Cancer research.

[60]  M. Schweitzer,et al.  Special focus session. MR arthrography. , 2002, Radiographics : a review publication of the Radiological Society of North America, Inc.

[61]  M. Hareyama,et al.  Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging. , 1999, International journal of radiation oncology, biology, physics.

[62]  M van Herk,et al.  The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer. , 1997, International journal of radiation oncology, biology, physics.

[63]  Mio Tanaka,et al.  Sinonasal NUT carcinoma: clinicopathological and cytogenetic analysis with autopsy findings. , 2018, Human pathology.

[64]  A. Jemal,et al.  Lung Cancer Statistics. , 2016, Advances in experimental medicine and biology.

[65]  P. Ramani,et al.  Sino nasal undifferentiated carcinoma: A rare entity , 2012, Journal of natural science, biology, and medicine.